FDA lifts curbs on Indian maker of malaria drug touted by Donald Trump as a Covid counter

Hydroxychloroquine is being snapped up by medical systems at more than twice the typical pace as U.S. hospitals seek to build large inventories in anticipation of the medication’s potential use in patients with Covid-19.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3bpkr2D
via IFTTT